GlassScriptPhysician profile
Hsin-Ying Lin
NPI 1568842706
$3,007.88
in general payments reported to CMS, 2019-2025
18 companies · $2,102 in 2025
The $2,102 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.68 · 2022: $119 · 2024: $744 · 2025: $2,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,787 · Education: $58.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,786.99 |
| Education | $58.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $393.74 | 2024-2025 | Tezspire, Airsupra |
| Actelion Pharmaceuticals US, INC. | $302.81 | 2024-2025 | Uptravi, Opsumit |
| Genzyme Corporation | $283.86 | 2024-2025 | |
| Verona Pharma, INC. | $283.09 | 2025 | Ohtuvayre |
| Gilead Sciences, INC. | $261.26 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $250.39 | 2024-2025 | Zerbaxa, Winrevair, Recarbrio |
| Glaxosmithkline, LLC. | $218.10 | 2022-2025 | Nucala, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.19 | 2024-2025 | Ofev, Jascayd |
| Bayer Healthcare Pharmaceuticals INC. | $140.00 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $139.95 | 2025 | Dupixent |
| Viatris Specialty LLC | $135.08 | 2025 | Yupelri |
| United Therapeutics Corporation | $128.52 | 2024-2025 | Tyvaso, Orenitram |
| Mylan Specialty L.P. | $79.37 | 2024 | Yupelri |
| Baxter Healthcare | $56.11 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Lilly USA, LLC | $45.39 | 2025 | Mounjaro, Zepbound |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $39.87 | 2025 | Smartvest |
| Philips North America LLC | $24.74 | 2024 | (Ak6) Vest Therapy |
| Organon LLC | $16.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hsin-Ying Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.